Teva to resume making pediatric cancer drug after shortage caused ‘a nightmare’
(By Maia Anderson for Becker’s Hospital Review) Teva Pharmaceuticals will resume producing the vital cancer drug vincristine after a shortage
Read More(By Maia Anderson for Becker’s Hospital Review) Teva Pharmaceuticals will resume producing the vital cancer drug vincristine after a shortage
Read MoreAccording to a recent Kaiser Health News analysis, some of the newest most expensive brand-name medicines have been plagued by
Read More(By Helen Branswell for STAT) Measles wipes out some of the immunity to other diseases that children acquire through vaccinations
Read More(By Andrew Joseph for STAT) The airways and lungs of some patients with a vaping-related illness appeared damaged in ways
Read MoreNearly one in 10 enrollees in Medicare 65 years of age and older, and four in 10 enrollees younger than
Read More(By Julie Appleby for Kaiser Health News) Medical treatment has knocked down tumors in 6-year-old Easton Daniels’ brain, but the
Read More(By James Love for STAT) When a new drug emerges from research largely funded by grants from charities and government
Read More(By Emily Vaughn for NPR) An outbreak of severe lung disease among users of electronic cigarettes continues to spread to
Read More(By Megan Thielking and Helen Branswell for STAT) Health officials are still scrambling to pinpoint the cause of an outbreak
Read More(By Bobby Allyn for NPR) Purdue Pharma, the maker of OxyContin, filed for Chapter 11 bankruptcy protection Sunday night, just
Read More